Employee-related Liabilities, Current of Twist Bioscience Corp from 30 Sep 2018 to 31 Dec 2025
- Taxonomy & unit
- us-gaap: USD
- Description
- Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
- Summary
-
Twist Bioscience Corp quarterly Employee-related Liabilities, Current in USD history and change rate from 30 Sep 2018 to 31 Dec 2025.
- Twist Bioscience Corp Employee-related Liabilities, Current for the quarter ending 31 Dec 2025 was $18,835,000, a 13% decline year-over-year.
- Source SEC data
- View on sec.gov
Employee-related Liabilities, Current, Quarterly (USD)
Employee-related Liabilities, Current, YoY Quarterly Change (%)
Twist Bioscience Corp Quarterly Employee-related Liabilities, Current (USD)
| Period | Value | YoY Chg | Change % | Date | Report | Filed | Fiscal Year | Fiscal Period |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | $18,835,000 | -$2,907,000 | -13% | 31 Dec 2025 | 10-Q/A | 26 Feb 2026 | 2026 | Q1 |
| Q3 2025 | $31,288,000 | -$2,362,000 | -7% | 30 Sep 2025 | 10-Q/A | 26 Feb 2026 | 2026 | Q1 |
| Q2 2025 | $28,972,000 | -$2,687,000 | -8.5% | 30 Jun 2025 | 10-Q | 04 Aug 2025 | 2025 | Q3 |
| Q1 2025 | $24,920,000 | -$294,000 | -1.2% | 31 Mar 2025 | 10-Q | 05 May 2025 | 2025 | Q2 |
| Q4 2024 | $21,742,000 | +$955,000 | +4.6% | 31 Dec 2024 | 10-Q | 03 Feb 2025 | 2025 | Q1 |
| Q3 2024 | $33,650,000 | +$7,832,000 | +30% | 30 Sep 2024 | 10-K | 17 Nov 2025 | 2025 | FY |
| Q2 2024 | $31,659,000 | +$4,375,000 | +16% | 30 Jun 2024 | 10-Q | 02 Aug 2024 | 2024 | Q3 |
| Q1 2024 | $25,214,000 | +$934,000 | +3.8% | 31 Mar 2024 | 10-Q | 02 May 2024 | 2024 | Q2 |
| Q4 2023 | $20,787,000 | -$2,490,000 | -11% | 31 Dec 2023 | 10-Q | 02 Feb 2024 | 2024 | Q1 |
| Q3 2023 | $25,818,000 | -$1,205,000 | -4.5% | 30 Sep 2023 | 10-K | 18 Nov 2024 | 2024 | FY |
| Q2 2023 | $27,284,000 | -$414,000 | -1.5% | 30 Jun 2023 | 10-Q | 07 Aug 2023 | 2023 | Q3 |
| Q1 2023 | $24,280,000 | +$2,594,000 | +12% | 31 Mar 2023 | 10-Q | 08 May 2023 | 2023 | Q2 |
| Q4 2022 | $23,277,000 | +$4,542,000 | +24% | 31 Dec 2022 | 10-Q | 07 Feb 2023 | 2023 | Q1 |
| Q3 2022 | $27,023,000 | +$4,696,000 | +21% | 30 Sep 2022 | 10-K | 21 Nov 2023 | 2023 | FY |
| Q2 2022 | $27,698,000 | +$8,175,000 | +42% | 30 Jun 2022 | 10-Q | 08 Aug 2022 | 2022 | Q3 |
| Q1 2022 | $21,686,000 | +$6,789,000 | +46% | 31 Mar 2022 | 10-Q | 06 May 2022 | 2022 | Q2 |
| Q4 2021 | $18,735,000 | +$7,158,000 | +62% | 31 Dec 2021 | 10-Q | 09 Feb 2022 | 2022 | Q1 |
| Q3 2021 | $22,327,000 | +$7,382,000 | +49% | 30 Sep 2021 | 10-K/A | 05 Jun 2023 | 2022 | FY |
| Q2 2021 | $19,523,000 | +$8,225,000 | +73% | 30 Jun 2021 | 10-Q | 09 Aug 2021 | 2021 | Q3 |
| Q1 2021 | $14,897,000 | +$6,272,000 | +73% | 31 Mar 2021 | 10-Q | 07 May 2021 | 2021 | Q2 |
| Q4 2020 | $11,577,000 | +$2,729,000 | +31% | 31 Dec 2020 | 10-Q | 09 Feb 2021 | 2021 | Q1 |
| Q3 2020 | $14,945,000 | +$4,466,000 | +43% | 30 Sep 2020 | 10-K | 23 Nov 2021 | 2021 | FY |
| Q2 2020 | $11,298,000 | +$1,412,000 | +14% | 30 Jun 2020 | 10-Q | 12 Aug 2020 | 2020 | Q3 |
| Q1 2020 | $8,625,000 | +$1,189,000 | +16% | 31 Mar 2020 | 10-Q | 13 May 2020 | 2020 | Q2 |
| Q4 2019 | $8,848,000 | +$3,587,000 | +68% | 31 Dec 2019 | 10-Q | 10 Feb 2020 | 2020 | Q1 |
| Q3 2019 | $10,479,000 | +$5,078,000 | +94% | 30 Sep 2019 | 10-K | 27 Nov 2020 | 2020 | FY |
| Q2 2019 | $9,886,000 | 30 Jun 2019 | 10-Q | 09 Aug 2019 | 2019 | Q3 | ||
| Q1 2019 | $7,436,000 | 31 Mar 2019 | 10-Q | 02 May 2019 | 2019 | Q2 | ||
| Q4 2018 | $5,261,000 | 31 Dec 2018 | 10-Q | 11 Feb 2019 | 2019 | Q1 | ||
| Q3 2018 | $5,401,000 | 30 Sep 2018 | 10-K | 13 Dec 2019 | 2019 | FY |
* An asterisk sign (*) next to the value indicates that the value is likely invalid.